Protein Details: Glutamate receptor 2

Protein ID

ICDB_Pro_0523

Protein Name

Glutamate receptor 2

Gene Name

GRIA2; GluA2; GLUR2

Organism

Homo sapiens (Human)

Length

883 amino acids

AlphaFoldDB

AF-P42262-F1-model_v4.pdb

Function

Ionotropic glutamate receptor that functions as a ligand-gated cation channel;gated by L-glutamate and glutamatergic agonists such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA);quisqualic acid;and kainic acid. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system and plays an important role in fast excitatory synaptic transmission. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change;leading to the opening of the cation channel;and thereby converts the chemical signal to an electrical impulse upon entry of monovalent and divalent cations such as sodium and calcium. The receptor then desensitizes rapidly and enters in a transient inactive state;characterized by the presence of bound agonist (By similarity). In the presence of CACNG4 or CACNG7 or CACNG8;shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of L-glutamate (By similarity). Through complex formation with NSG1;GRIP1 and STX12 controls the intracellular fate of AMPAR and the endosomal sorting of the GRIA2 subunit toward recycling and membrane targeting (By similarity).

Sequence

MQKIMHISVLLSPVLWGLIFGVSSNSIQIGGLFPRGADQEYSAFRVGMVQFSTSEFRLTPHIDNLEVANSFAVTNAFCSQFSRGVYAIFGFYDKKSVNTITSFCGTLHVSFITPSFPTDGTHPFVIQMRPDLKGALLSLIEYYQWDKFAYLYDSDRGLSTLQAVLDSAAEKKWQVTAINVGNINNDKKDEMYRSLFQDLELKKERRVILDCERDKVNDIVDQVITIGKHVKGYHYIIANLGFTDGDLLKIQFGGANVSGFQIVDYDDSLVSKFIERWSTLEEKEYPGAHTTTIKYTSALTYDAVQVMTEAFRNLRKQRIEISRRGNAGDCLANPAVPWGQGVEIERALKQVQVEGLSGNIKFDQNGKRINYTINIMELKTNGPRKIGYWSEVDKMVVTLTELPSGNDTSGLENKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHTEEFEDGRETQSSESTNEFGIFNSLWFSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKEKTSALSLSNVAGVFYILVGGLGLAMLVALIEFCYKSRAEAKRMKVAKNAQNINPSSSQNSQNFATYKEGYNVYGIESVKI

PDB Structures

Ligand Binding

1. DICL_CP

2. DICL_Pep

Binding Site

BINDING 499; /ligand="L-glutamate"; BINDING 501; /ligand="L-glutamate"; BINDING 506; /ligand="L-glutamate";ECO:0000269|PubMed:21531559;ECO:0007744|PDB:2XHD;ECO:0007744|PDB:3R7X"; BINDING 675; /ligand="L-glutamate";ECO:0007744|PDB:2XHD"; BINDING 676; /ligand="L-glutamate";ECO:0007744|PDB:2XHD"; BINDING 726; /ligand="L-glutamate";ECO:0000269|PubMed:21531559;ECO:0007744|PDB:2XHD"

Disease

Neurodevelopmental Disorder With Language Impairment And Behavioral Abnormalities and Gria2-Related Neurodevelopmental Disorder

Location

DOI ID

10.1097/00001756-199401120-00018; 10.1038/nature03466; 10.1101/gr.2596504; 10.1046/j.1471-4159.1994.63051596.x; 10.1016/s0896-6273(03)00722-0; 10.1074/jbc.m404499200; 10.1073/pnas.1217477109; 10.1523/jneurosci.2626-12.2013; 10.1016/j.jmb.2009.07.082; 10.1021/jm1005429; 10.1016/j.bmcl.2011.04.017; 10.1038/s41467-019-10910-w

RefSeq

NP_000817.2 [P42262-2]; NP_001077088.1 [P42262-1]; NP_001077089.1 [P42262-4]; XP_016863605.1; XP_016863606.1

Feature